Why we can’t stop US drug companies from charging astronomical prices

In August, Turing Pharmaceuticals, a startup biotech firm founded by controversial ex-hedge funder Martin Shkreli bought a 62-year-old drug that mostly treats infections in AIDS patients and others with suppressed immune systems. Overnight, its cost increased from $13.50 a pill to $750.

Source: Why we can’t stop US drug companies from charging astronomical prices
Picture: Quartz (Reuters/Ronen Zvulun)
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s